Artiva CEO Aslan sells 23,463 shares
Artiva Biotherapeutics CEO Fred Aslan reported a sale of 23,463 shares at $7.20 each, for $168,880, in a Form 4 filing. The filing says the transaction was made under a 10b5-1 plan.
Artiva Biotherapeutics CEO Fred Aslan reported a sale of 23,463 shares at $7.20 each, for $168,880, in a Form 4 filing. The filing says the transaction was made under a 10b5-1 plan.